Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-17 5:42 pm Purchase | 13G | PALVELLA THERAPEUTICS INC. PVLA | BIOTECHNOLOGY VALUE FUND L P | 1,168,117 9.990% | 1,168,117 (New Position) | View |
| 2024-12-04 7:49 pm Sale | 13D | Olema Pharmaceuticals Inc. OLMA | BIOTECHNOLOGY VALUE FUND L P | 7,557,237 9.990% | -1,578,656 (-17.28%) | View |
| 2024-11-21 8:27 pm Purchase | 13G | iTeos Therapeutics Inc. ITOS | BIOTECHNOLOGY VALUE FUND L P | 2,325,000 6.400% | 1,065,524 (+84.60%) | View |
| 2024-11-18 5:23 pm Purchase | 13G | Verve Therapeutics Inc. VERV | BIOTECHNOLOGY VALUE FUND L P | 6,904,050 8.200% | 6,904,050 (New Position) | View |
| 2024-11-14 4:40 pm Purchase | 13G | TScan Therapeutics Inc. TCRX | BIOTECHNOLOGY VALUE FUND L P | 5,073,003 9.990% | 658,093 (+14.91%) | View |
| 2024-11-14 4:39 pm Sale | 13G | Ovid Therapeutics Inc. OVID | BIOTECHNOLOGY VALUE FUND L P | 3,853,818 5.400% | -2,997,233 (-43.75%) | View |
| 2024-11-14 4:38 pm Purchase | 13G | Verastem Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 4,279,521 9.990% | 1,662,119 (+63.50%) | View |
| 2024-11-14 4:37 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | BIOTECHNOLOGY VALUE FUND L P | 672,767 9.990% | 135,341 (+25.18%) | View |
| 2024-11-14 4:37 pm Sale | 13G | MIRUM PHARMACEUTICALS INC MIRM | BIOTECHNOLOGY VALUE FUND L P | 3,075,907 6.400% | -1,294,117 (-29.61%) | View |
| 2024-11-14 4:36 pm Purchase | 13G | Annexon Inc. ANNX | BIOTECHNOLOGY VALUE FUND L P | 9,027,778 8.400% | 2,027,778 (+28.97%) | View |
| 2024-11-14 4:36 pm Purchase | 13G | AC Immune SA ACIU | BIOTECHNOLOGY VALUE FUND L P | 19,522,436 19.700% | 4,951,200 (+33.98%) | View |
| 2024-11-14 4:34 pm Purchase | 13G | TYRA BIOSCIENCES INC TYRA | BIOTECHNOLOGY VALUE FUND L P | 4,661,194 8.800% | 1,921,599 (+70.14%) | View |
| 2024-11-14 4:33 pm Sale | 13G | VIRACTA THERAPEUTICS INC VIRX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -3,833,785 (Position Closed) | View |
| 2024-11-14 4:32 pm Sale | 13G | KURA ONCOLOGY INC KURA | BIOTECHNOLOGY VALUE FUND L P | 4,212,346 5.400% | -3,160,882 (-42.87%) | View |
| 2024-11-14 4:32 pm Purchase | 13G | REGULUS THERAPEUTICS INC P RGLS | BIOTECHNOLOGY VALUE FUND L P | 883,844 1.300% | 883,844 (New Position) | View |
| 2024-11-14 4:30 pm Sale | 13G | SUTRO BIOPHARMA INC. STRO | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -3,347,946 (Position Closed) | View |
| 2024-11-14 4:30 pm Sale | 13G | 89bio Inc. ETNB | BIOTECHNOLOGY VALUE FUND L P | 6,811,631 6.400% | -756,849 (-10.00%) | View |
| 2024-11-14 4:29 pm Sale | 13G | AN2 Therapeutics Inc. ANTX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -1,563,963 (Position Closed) | View |
| 2024-11-14 4:29 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | BIOTECHNOLOGY VALUE FUND L P | 10,471,230 9.990% | 7,001,005 (+201.74%) | View |
| 2024-11-14 4:28 pm Purchase | 13G | Elevation Oncology Inc. ELEV | BIOTECHNOLOGY VALUE FUND L P | 6,230,845 9.990% | 1,779,960 (+39.99%) | View |